BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 18601810)

  • 1. CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences.
    Florence WC; Bhat RK; Joyce S
    Expert Rev Mol Med; 2008 Jul; 10():e20. PubMed ID: 18601810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vivo response of invariant natural killer T cells to glycolipid antigens.
    Parekh VV; Lalani S; Van Kaer L
    Int Rev Immunol; 2007; 26(1-2):31-48. PubMed ID: 17454263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
    Miyake S; Yamamura T
    Int Rev Immunol; 2007; 26(1-2):73-94. PubMed ID: 17454265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity.
    Nieuwenhuis EE; Gillessen S; Scheper RJ; Exley MA; Taniguchi M; Balk SP; Strominger JL; Dranoff G; Blumberg RS; Wilson SB
    Exp Dermatol; 2005 Apr; 14(4):250-8. PubMed ID: 15810882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
    Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
    Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity.
    Wilson SB; Delovitch TL
    Nat Rev Immunol; 2003 Mar; 3(3):211-22. PubMed ID: 12658269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
    van der Vliet HJ; Molling JW; von Blomberg BM; Nishi N; Kölgen W; van den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ
    Clin Immunol; 2004 Jul; 112(1):8-23. PubMed ID: 15207777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.
    Cohen NR; Garg S; Brenner MB
    Adv Immunol; 2009; 102():1-94. PubMed ID: 19477319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury.
    Ström A; Wigren M; Hultgårdh-Nilsson A; Saxena A; Gomez MF; Cardell S; Fredrikson GN; Nilsson J
    Circ Res; 2007 Oct; 101(8):e83-9. PubMed ID: 17885216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood.
    Jing Y; Gravenstein S; Chaganty NR; Chen N; Lyerly KH; Joyce S; Deng Y
    Exp Gerontol; 2007 Aug; 42(8):719-32. PubMed ID: 17368996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iNKT cells in microbial immunity: recognition of microbial glycolipids.
    Kinjo Y; Ueno K
    Microbiol Immunol; 2011 Jul; 55(7):472-82. PubMed ID: 21434991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invariant natural killer T cells and immunotherapy of cancer.
    Molling JW; Moreno M; van der Vliet HJ; van den Eertwegh AJ; Scheper RJ; von Blomberg BM; Bontkes HJ
    Clin Immunol; 2008 Nov; 129(2):182-94. PubMed ID: 18783990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD1 proteins: targets of T cell recognition in innate and adaptive immunity.
    Ulrichs T; Porcelli SA
    Rev Immunogenet; 2000; 2(3):416-32. PubMed ID: 11256748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the behavior of invariant NKT cells in autoimmune diseases.
    Yamamura T; Sakuishi K; Illés Z; Miyake S
    J Neuroimmunol; 2007 Nov; 191(1-2):8-15. PubMed ID: 17905445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer T cells and haemopoiesis.
    Karadimitris A; Patterson S; Spanoudakis E
    Br J Haematol; 2006 Aug; 134(3):263-72. PubMed ID: 16848769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells.
    Chen S; Ndhlovu LC; Takahashi T; Takeda K; Ikarashi Y; Kikuchi T; Murata K; Pandolfi PP; Riccardi C; Ono M; Sugamura K; Ishii N
    Eur J Immunol; 2008 Aug; 38(8):2229-40. PubMed ID: 18624295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of pollen-derived phosphatidyl-ethanolamine by human CD1d-restricted gamma delta T cells.
    Russano AM; Agea E; Corazzi L; Postle AD; De Libero G; Porcelli S; de Benedictis FM; Spinozzi F
    J Allergy Clin Immunol; 2006 May; 117(5):1178-84. PubMed ID: 16675349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.